It may be due to the low proportion of patients with positive PEDF expression (only 8.9%; 15/168) and the high rate of 5-years survival in NPC patients (69.0%, 116/168) (Supplementary Fig. S3). The gene discussed is SERPINF1; the disease is nasopharyngeal carcinoma.